================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2005
Commission file number 1-12372
CYTEC INDUSTRIES INC.
(Exact name of registrant as specified in its charter)
Delaware 22-3268660
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification No).
Five Garret Mountain Plaza
West Paterson, New Jersey 07424
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (973) 357-3100
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports) and (2) has been subject to such filing
requirements for the past 90 days.
Yes |X| No |_|
Indicate by check mark whether the Registrant is an accelerated filer (as
defined in Rule 12b-2 of the Exchange Act).
Yes |X| No |_|
There were 45,965,638 shares of common stock outstanding at April 25, 2005.
-1-
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
10-Q Table of Contents
Page
Part I - Financial Information
Item 1. Consolidated Financial Statements 3
Consolidated Statements of Operations 3
Consolidated Balance Sheets 4
Consolidated Statements of Cash Flows 5
Notes to Consolidated Financial Statements 6
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 18
Item 3. Quantitative and Qualitative Disclosures About Market Risk 24
Item 4. Controls and Procedures 24
Part II - Other Information
Item 1. Legal Proceedings 25
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26
Item 6. Exhibits 27
Signature 28
Exhibit Index 29
-2-
PART I - FINANCIAL INFORMATION
Item 1. CONSOLIDATED FINANCIAL STATEMENTS
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in millions, except per share amounts)
Three Months Ended
March 31,
------------------------
2005 2004 (1)
- ------------------------------------------------------------------------------------------------------------------------
Net sales $563.9 $415.2
Manufacturing cost of sales 440.3 310.1
Selling and technical services 44.7 34.8
Research and process development 13.0 9.0
Administrative and general 17.8 13.2
Amortization of acquisition intangibles 4.0 1.4
Write-off of acquired in-process research and development 37.0 -
- ------------------------------------------------------------------------------------------------------------------------
Earnings from operations 7.1 46.7
Other income (expense), net (20.4) 0.9
Equity in earnings of associated companies 2.1 0.3
Interest expense, net 9.5 3.8
- ------------------------------------------------------------------------------------------------------------------------
Earnings (loss) from continuing operations before income taxes (20.7) 44.1
Income tax provision (benefit) (13.7) 10.9
- ------------------------------------------------------------------------------------------------------------------------
Earnings (loss) from continuing operations (7.0) 33.2
Earnings from discontinued operations held for sale (net of income tax provision of $0.7) 0.5 -
- ------------------------------------------------------------------------------------------------------------------------
Net earnings (loss) $(6.5) $33.2
- ------------------------------------------------------------------------------------------------------------------------
Basic net earnings (loss) per common share:
Earnings (loss) from continuing operations $(0.17) $0.85
Earnings from discontinued operations held for sale 0.01 -
- ------------------------------------------------------------------------------------------------------------------------
Net earnings (loss) $(0.16) $0.85
- ------------------------------------------------------------------------------------------------------------------------
Diluted net earnings (loss) per common share:
Earnings (loss) from continuing operations $(0.17) $0.83
Earnings from discontinued operations held for sale 0.01 -
- ------------------------------------------------------------------------------------------------------------------------
Net earnings (loss) $(0.16) $0.83
- ------------------------------------------------------------------------------------------------------------------------
Dividends per common share $0.10 $0.10
- ------------------------------------------------------------------------------------------------------------------------
(1) 2004 results were restated to show the effect of FSP 106-2, which was
adopted retroactively during the third quarter of 2004, and the retroactive
application of the change from the LIFO to the FIFO inventory method which was
adopted on January 1, 2005. Refer to Note 1.
See accompanying Notes to Consolidated Financial Statements
-3-
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in millions, except per share amounts)
March 31, December 31,
2005 2004 (1)
- -----------------------------------------------------------------------------------------------
Assets
Current assets
Cash and cash equivalents $76.7 $323.8
Trade accounts receivable, less allowance for doubtful accounts
of $9.2 and $6.7 in 2005 and 2004, respectively 493.2 248.2
Due from related party 21.7 -
Other accounts receivable 96.7 54.1
Inventories 516.7 263.8
Deferred income taxes 61.9 23.3
Other current assets 51.0 29.3
Assets of discontinued operations held for sale 144.6 -
- -----------------------------------------------------------------------------------------------
Total current assets 1,462.5 942.5
- -----------------------------------------------------------------------------------------------
Investment in associated companies 90.9 85.5
Plants, equipment and facilities, at cost 2,080.0 1,627.2
Less: accumulated depreciation (940.3) (948.6)
- -----------------------------------------------------------------------------------------------
Net plant investment 1,139.7 678.6
- -----------------------------------------------------------------------------------------------
Acquisition intangibles, net of accumulated amortization of
$26.5 and $23.1 in 2005 and 2004, respectively 554.7 66.8
Goodwill 1,004.7 342.4
Deferred income taxes - 54.6
Other assets 117.4 81.2
- -----------------------------------------------------------------------------------------------
Total assets $4,369.9 $2,251.6
- -----------------------------------------------------------------------------------------------
Liabilities
Current liabilities
Accounts payable $271.1 $138.1
Short-term borrowings 613.7 -
Current maturities of long-term debt 84.9 119.0
Accrued expenses 217.8 178.1
Income taxes payable 65.0 61.5
Liabilities of discontinued operations held for sale 35.5 -
- -----------------------------------------------------------------------------------------------
Total current liabilities 1,288.0 496.7
- -----------------------------------------------------------------------------------------------
Long-term debt 1,081.4 300.1
Pension and other postretirement benefit liabilities 387.6 348.3
Deferred income taxes 144.3 -
Other noncurrent liabilities 251.7 174.5
Stockholders' equity
Common stock, $.01 par value per share, 150,000,000 shares
authorized; issued 48,132,640 shares 0.5 0.5
Additional paid-in capital 236.5 122.8
Retained earnings 1,098.0 1,108.5
Accumulated other comprehensive income (loss):
Unearned compensation (5.4) (3.1)
Minimum pension liability (109.5) (108.5)
Unrealized net gains (losses) on cash flow hedges 1.1 (0.5)
Accumulated translation adjustments 64.7 73.3
- -----------------------------------------------------------------------------------------------
(49.1) (38.8)
Treasury stock, at cost, 2,191,352 shares in 2005 and 8,297,863
shares in 2004 (69.0) (261.0)
- -----------------------------------------------------------------------------------------------
Total stockholders' equity 1,216.9 932.0
- -----------------------------------------------------------------------------------------------
Total liabilities and stockholders' equity $4,369.9 $2,251.6
- -----------------------------------------------------------------------------------------------
(1) Balances at December 31, 2004 have been restated to show the retroactive
application of the change from the LIFO to the FIFO inventory method which was
adopted on January 1, 2005. Refer to Note 1.
See accompanying Notes to Consolidated Financial Statements
-4-
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in millions)
----------------------
Three Months Ended
March 31,
- ---------------------------------------------------------------------------------------
2005 2004 (1)
- ---------------------------------------------------------------------------------------
Cash flows provided by (used in) operating activities
Net earnings (loss) from continuing operations $(7.0) $33.2
Noncash items included in net earnings from continuing
operations:
Dividends from associated company greater than (less than)
earnings (1.0) 0.8
Depreciation 23.3 21.6
Amortization 5.1 2.7
Deferred income taxes (8.2) 7.3
Write-off of acquired in-process research and development 37.0 -
Gain on sale of assets (1.0) (0.6)
Tax benefit related to completion of prior year audits (16.2) -
Other (1.1) (0.3)
Changes in operating assets and liabilities (excluding effect
of acquisitions):
Trade accounts receivable (5.4) (28.9)
Other receivables 4.4 (3.8)
Inventories (21.2) (11.0)
Other assets 0.5 (8.0)
Accounts payable (7.8) 44.0
Accrued expenses (13.8) (24.6)
Income taxes payable (8.2) 1.0
Other liabilities (11.1) (10.7)
- ---------------------------------------------------------------------------------------
Net cash provided by (used in) operating activities of
continuing operations (31.7) 22.7
Net cash provided by operating activities of discontinued
operations 1.1 -
- ---------------------------------------------------------------------------------------
Net cash provided by (used in) operating activities (30.6) 22.7
- ---------------------------------------------------------------------------------------
Cash flows (used in) investing activities
Additions to plants, equipment and facilities (17.1) (16.9)
Proceeds received on sale of assets 1.4 0.7
Acquisition of business, net of cash received (1,474.6) -
Advanced payment of acquisition-related contingent
consideration (26.5) -
Minority interest (1.0)
Advance payment received on land lease - 9.1
- ---------------------------------------------------------------------------------------
Net cash used in investing activities (1,517.8) (7.1)
- ---------------------------------------------------------------------------------------
Cash flows provided by (used in) financing activities
Proceeds from the exercise of stock options and warrants 8.8 2.9
Cash dividends (4.0) (3.9)
Proceeds from long-term debt 725.0 -
Change in short-term borrowings 581.9 (0.1)
Deferred financing costs (4.7) -
Purchase of treasury stock - (13.2)
Proceeds from termination of interest rate swap - 2.7
- ---------------------------------------------------------------------------------------
Net cash provided by (used in) financing activities 1,307.0 (11.6)
- ---------------------------------------------------------------------------------------
Effect of currency rate changes on cash and cash equivalents (5.7) (3.5)
- ---------------------------------------------------------------------------------------
Increase (decrease) in cash and cash equivalents (247.1) 0.5
Cash and cash equivalents, beginning of period 323.8 251.1
- ---------------------------------------------------------------------------------------
Cash and cash equivalents, end of period $76.7 $251.6
- ---------------------------------------------------------------------------------------
(1) 2004 results were restated to show the effect of FSP 106-2, which was
adopted retroactively during the third quarter of 2004, and the retroactive
application of the change from the LIFO to the FIFO inventory method which was
adopted on January 1, 2005. Refer to Note 1.
See accompanying Notes to Consolidated Financial Statements
-5-
CYTEC INDUSTRIES INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
(Dollars in millions, except per share amounts, unless otherwise indicated)
1. BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements included herein
have been prepared pursuant to the rules and regulations of the Securities and
Exchange Commission for reporting on Form 10-Q. Certain information and footnote
disclosures normally included in financial statements prepared in accordance
with accounting principles generally accepted in the United States of America
("U.S. GAAP") have been condensed or omitted pursuant to such rules and
regulations. Financial statements prepared in accordance with U.S. GAAP require
management to make certain estimates and assumptions that affect the reported
amounts of assets and liabilities, revenues and expenses and other disclosures.
In the opinion of management of Cytec Industries Inc. (the "Company"), these
financial statements include all normal and recurring adjustments necessary for
a fair presentation of the financial position and the results of operations and
cash flows of the Company for the interim periods presented. The results of
operations for any interim period are not necessarily indicative of the results
of operations for the full year. The statements should be read in conjunction
with the Consolidated Financial Statements and Notes to the Consolidated
Financial Statements contained in the Company's 2004 Annual Report on Form 10-K.
Unless indicated otherwise, the terms "Company" and "Cytec" each refer
collectively to Cytec Industries Inc. and its subsidiaries.
Restatement for Change in Accounting Principle: Effective January 1, 2005, the
Company changed its inventory costing method for U.S. inventories from the
last-in, first-out ("LIFO") method to the first-in, first-out ("FIFO") method.
Management of the Company believes that the FIFO method is preferable to LIFO
because FIFO inventory values presented in the Company's balance sheet will more
accurately reflect the current value of inventory and the change to FIFO for
U.S. inventories results in the Company using a uniform method of inventory
valuation globally. Additionally, as a result of the acquisition of Surface
Specialties (as described in Note 2), had the Company's existing U.S. operations
retained its practice of valuing its inventories on LIFO, less than 35% of the
Company's total inventories would have been valued under the LIFO method as of
March 31, 2005. Prior to the retroactive restatement for the change in cost
method, operations using the LIFO cost method comprised almost 60% of the
Company's inventories as of December 31, 2004.
The Company has applied this change retroactively by restating its financial
statements as required by Accounting Principles Board Opinion No. 20,
"Accounting Changes," and accordingly, previously reported amounts in the
accompanying financial statements have been restated for all periods presented.
As a result of this change, inventories at December 31, 2004 were increased by
$41.7, retained earnings were increased by $25.4 and deferred income tax assets
were decreased by $16.3. See the table below for the effects on the results of
operations for the quarter ended March 31, 2004 as a result of the retroactive
restatement of the financial statements related to the change in accounting
principle. The Company has not calculated and presented herein the impact on
2005 results if the Company had stayed on LIFO as the information is not
believed to be meaningful given the acquisition completed on February 28, 2005.
As soon as practicable, the Company will issue a Current Report on Form 8-K to
restate its previously issued financial statements for all years shown in the
Company's 2004 Annual Report on Form 10-K.
Restatement for Adoption of FSP 106-2: The results of operations for the period
ended March 31, 2004 included herein have been restated to show the effects of
adopting the provisions of Financial Accounting Standards Board ("FASB") Staff
Position No. 106-2, "Accounting and Disclosure Requirements Related to the
Medicare Prescription Drug, Improvement and Modernization Act of 2003" ("FSP
106-2"). In December 2003, Congress passed the Medicare Prescription Drug,
Improvement and Modernization Act of 2003. In May 2004, the FASB issued FSP
106-2 which requires companies to account for the reduction in accumulated
postretirement benefit obligation as an actuarial gain to be amortized into
income over the average remaining service period of plan participants. The
Company adopted the provisions of FSP 106-2 in the third quarter of 2004,
retroactive to January 1, 2004, as permitted by FSP 106-2.
As a result of the retroactive adoption of FSP 106-2 and the FIFO method of
inventory valuation discussed above, net
-6-
earnings and earnings per share for the quarter ended March 31, 2004 have been
restated as follows:
- -----------------------------------------------------------------------
Three Months
Ended
March 31, 2004
- -----------------------------------------------------------------------
Net earnings, as originally reported $ 31.3
Effect of retroactive adoption of FIFO 1.2
Effect of adopting FSP 106-2 0.7
- -----------------------------------------------------------------------
Net earnings, as restated $ 33.2
- -----------------------------------------------------------------------
Basic net earnings per share, as originally reported $ 0.80
Effect of retroactive adoption of FIFO 0.03
Effect of adopting FSP 106-2 0.02
- -----------------------------------------------------------------------
Basic net earnings per share, as restated $ 0.85
- -----------------------------------------------------------------------
Diluted net earnings per share, as originally $ 0.78
reported
Effect of retroactive adoption of FIFO 0.03
Effect of adopting FSP 106-2 0.02
- -----------------------------------------------------------------------
Diluted net earnings per share, as restated $ 0.83
- -----------------------------------------------------------------------
Certain reclassifications have been made to the prior year's financial
statements in order to conform to the current year's presentation.
2. RECENT ACQUISITION AND RELATED EVENTS
On February 28, 2005, the Company completed its acquisition of the Surface
Specialties business ("Surface Specialties") of UCB Group ("UCB"), a Belgium
biopharmaceutical and specialty chemical company, for cash and stock valued at
$1,799.6 of which $1,508.8 (euro 1138.5 at 1.325 U.S. dollar per euro) was paid
in cash and the balance was paid in 5,772,857 shares of Cytec common stock
($290.8 at $50.37 per Cytec share, based on the five-day average value of the
shares before and after February 7, 2005, the date on which the terms of the
amended acquisition agreement were announced). In addition, there is contingent
consideration up to a maximum of 50 million euros, of which 20 million euros
($26.5 at 1.325 US dollar per euro) was paid upon closing, subject to refund,
and is not included in the total consideration of $1,799.6, with the balance
potentially payable in 2006. The contingent consideration is included in other
assets in the accompanying balance sheet and will be earned on a pro-rata basis
pending the achievement of certain full-year operating results by Surface
Specialties in 2005. If the contingent consideration is earned, goodwill would
be increased. The cash purchase price was also preliminarily adjusted as a
result of working capital levels, including cash and certain debt balances which
were transferred to the Company at closing. In addition, $12.0 of transaction
costs were incurred in connection with the acquisition, some of which remain
unpaid at March 31, 2005.
The Company financed the cash component with $600.0 under an unsecured 364-day
credit facility, $725.0 under an unsecured five-year term loan and the remaining
$184.0 was paid from existing cash. The Company intends to refinance the 364-day
borrowing with long-term debt. Refer to Note 9 for other disclosures concerning
the Company's debt.
Upon closing, UCB became the owner of approximately 12.5% of the outstanding
shares of the Company. UCB and the Company also entered into a stockholder's
agreement (the "Stockholder's Agreement") which provides, subject to various
exception, that UCB must reduce its stake to less than 9% within three years,
less than 7% within four years and less than 5% within five years and which
provides that UCB will be prohibited from purchasing additional shares of Cytec
common stock or causing, advocating or participating in a change of control in
the ownership of Cytec. The Stockholders Agreement also contains customary terms
and conditions including an obligation of UCB to vote its shares of Cytec common
stock in accordance with the Company's Board of Directors' recommendation on
certain matters.
-7-
The global Surface Specialties business had revenues of approximately $1,350 in
2004 which included approximately $154 of sales from the Surface Specialties
amino resins ("SSAR") product line. Pursuant to regulatory approvals, the
Company is required to divest SSAR by September, 2005. Until such time as SSAR
is sold, results of its operations will be classified as discontinued operations
in the Company's consolidated statement of operations. The net after-tax
proceeds realized from the divestiture of SSAR will be used to reduce debt. The
assets and liabilities of SSAR have been classified separately in the Company's
consolidated balance sheet. Refer to Note 4 for additional information relating
to discontinued operations.
The acquisition complements Cytec's existing product lines in the Performance
Products segment by significantly increasing Cytec's product offering to the
coatings and additives industries including the general industrial, automotive,
architectural, plastic, graphic arts and wood sectors. Cytec is operating the
Surface Specialties business as a separate segment and is in the process of
integrating its coating and performance chemicals product lines, formerly part
of the Performance Products segment, into the new segment which has been named
Cytec Surface Specialties. The remaining product lines in the Performance
Products segment are being combined with the Water and Industrial Process
segment, which has been renamed Cytec Performance Specialties. Additionally, the
Specialty Materials Segment has been renamed Cytec Engineered Materials. Refer
to Note 14 for disclosures about segment information, which has been restated to
reflect the new organizational structure for all periods presented.
The Company had previously entered into $623.2 of forward-starting interest rate
swaps to hedge the benchmark interest rate and credit spread on a portion of the
long-term debt that will be issued in 2005 to refinance the bank debt
outstanding under the 364-day credit facility that was drawn for the acquisition
of Surface Specialties. The credit spread portions of the swaps were
representative of AA-rated 10-year notes and served as a proxy credit spread for
the Company. In March 2005, the Company extended the maturity date of $598.2 of
the $623.2 swaps to June 2005. Due to a reduction in borrowing requirements, the
Company liquidated its remaining $25.0 forward starting interest rate swap in
March 2005 at a cost of $0.4. The swaps are being marked to market and recorded
currently in earnings until maturity or settlement. The net pre-tax impact of
the marked to market value on these swaps was a loss of $0.8 which was recorded
in other income (expense), net for the quarter ended March 31, 2005. In the
fourth quarter of 2004, the Company recorded a loss of $6.5 on interest rate
swap transactions entered into in connection with the acquisition.
The Company had also previously entered into foreign currency forward contracts
totaling 1.037 billion euros that related to approximately 87% of the euro
exposure of 1.190 billion for the cash component of the Surface Specialties
acquisition. The forward contracts, which matured on February 28, 2005, were
marked to market and recorded currently in earnings until their maturity. The
impact on earnings for the quarter ended March 31, 2005 of the mark to market
adjustment on these forward contracts was a net pre-tax expense of $19.2 and was
recorded in other income (expense), net. In the fourth quarter of 2004, the
Company recorded a gain of $33.3 on currency forward transactions entered into
in connection with the acquisition.
In connection with the acquisition, the Company suspended its stock buy-back
program and does not anticipate making future stock buy-backs for at least two
years from the closing date in order to maximize the funds available for debt
service and other corporate purposes.
The following table summarizes the estimated fair value of the assets acquired
and the liabilities assumed in the acquisition. The Company is in the process of
finalizing third-party valuations of certain assets acquired and liabilities
assumed, as well as performing its own internal assessment; thus the table below
discloses a preliminary allocation of the purchase price. The preliminary
allocation is subject to change, and such change could be significant. The
Company expects to have the purchase price allocation substantially complete
later in 2005.
- -----------------------------------------------------------------------
Cash $ 34.7
Current deferred tax assets 40.5
Other current assets 561.6
Assets of discontinued operations held for sale 135.4
Property, plant and equipment 478.4
Goodwill 671.1
Acquired intangible assets 490.8
Acquired in-process research and development 37.0
Other assets 17.4
- -----------------------------------------------------------------------
Total assets acquired $2,466.9
- -----------------------------------------------------------------------
Current liabilities $ 281.0
Liabilities of discontinued operations held for sale 25.4
Long-term deferred tax liabilities 209.6
Long-term debt 9.7
Other long-term liabilities 129.6
- -----------------------------------------------------------------------
Total liabilities assumed 655.3
- -----------------------------------------------------------------------
Net assets acquired $1,811.6
- -----------------------------------------------------------------------
-8-
The $671.1 of goodwill is not tax deductible and was allocated to the Company's
Cytec Surface Specialties segment. The preliminary purchase price allocation
reflects an estimate of $527.8 of acquired intangible assets. Included in
acquired intangible assets is $45.7 relating to certain tradenames which have
indefinite useful lives. The remaining intangibles that were acquired were
assigned to customer-related ($382.5), marketing-related ($50.8) and
technology-related intangibles ($11.8), and are being amortized over periods of
10 to 15 years. Immediately following the acquisition, $37.0 of acquired
in-process research and development costs were written off.
Following are the unaudited pro forma combined results of operations for the
quarters ended March 31, 2005 and 2004 as if Cytec and Surface Specialties had
been combined as of the beginning of each of the periods presented but excludes
the results of SSAR which became a discontinued operation as of the date of
acquisition. Additionally, the write-off of in-process research and development
costs and inventory valuation adjustments were excluded from the 2005 and 2004
amounts as they are considered non-recurring charges. The pro forma results
include estimates and assumptions which are subject to adjustment pending
completion of the purchase price allocation and will also be affected by final
working capital and other customary adjustments. However, pro forma results do
not include any anticipated cost savings or other effects of the planned
integration and are not indicative of the results which would have actually
occurred if the business combination had been in effect on the dates indicated,
or which may result in the future. The pro forma information set forth below
considers the following factors: the issuance of 5,772,857 shares of Cytec
common stock to UCB in connection with the acquisition; the anticipated sale of
SSAR; the issuance of acquisition-related debt of $1,325.0 at a weighted-average
interest rate of 3.79% and the associated increase in interest expense, net of
the after tax proceeds from the anticipated sale of SSAR used to pay down such
debt; a net reduction in cash and an associated reduction in interest income as
a result of the on-hand cash utilized to purchase Surface Specialties; increased
amortization of acquisition intangibles; decreased depreciation expense based on
asset values and estimated useful lives included in the preliminary valuation
report; amortization of deferred financing costs and the tax effects of each of
these items.
- --------------------------------------------------------------------
Three Months Ended
March 31,
- --------------------------------------------------------------------
2005 2004
- --------------------------------------------------------------------
Revenues $ 788.7 $ 706.3
Net earnings $ 39.8 $ 45.5
Net earnings per common share:
Basic $ 0.87 $ 1.02
Diluted $ 0.84 $ 1.00
3. ACCOUNTING PRONOUNCEMENTS
Recently Issued Accounting Pronouncements: In December, 2004, the FASB issued
SFAS No. 123 (revised 2004), "Share-Based Payment" ("SFAS 123R"). SFAS 123R
addresses the accounting for transactions in which an enterprise receives
employee services in exchange for (a) equity instruments of the enterprise or
(b) liabilities that are based on the fair value of the enterprise's equity
instruments or that may be settled by the issuance of such equity instruments.
When SFAS 123R becomes effective, it will replace SFAS No. 123 and supersede
Accounting Principles Board Opinion No. 25, "Accounting for Stock Issued to
Employees," ("APB No. 25") and will require companies to recognize compensation
expense in an amount equal to the fair value of share-based payments, such as
stock options granted to employees. Companies were required to implement the
proposed standard no later than July 1, 2005, however, the Securities and
Exchange Commission issued a statement in April, 2005 that allows registrants to
implement FAS 123R at the beginning of their next fiscal year. The Company
anticipates that it will adopt the new standard effective January 1, 2006
utilizing the modified prospective basis as allowed under FAS 123R (see Note 5).
In November 2004, the FASB issued SFAS No. 151, "Inventory Costs - An amendment
of ARB No. 43, Chapter 4" ("SFAS 151"). SFAS 151 amends the guidance in ARB No.
43, Chapter 4, "Inventory Pricing," to clarify the accounting for abnormal
amounts of idle facility expense, freight, handling costs, and wasted material
(spoilage). Additionally, SFAS No. 151 requires that the allocation of fixed
production overheads to the costs of conversion be based on the normal capacity
of the production facilities. SFAS No. 151 is required to be adopted by the
Company in the first quarter of 2006. The Company is currently evaluating the
impact of SFAS 151 on its consolidated financial statements.
-9-
4. DISCONTINUED OPERATIONS
Pursuant to regulatory approvals, the Company is required to divest SSAR by
September, 2005. SSAR develops and manufactures amino resins for use in various
industries. SSAR has assets and liabilities that are located primarily in the
U.S., Canada and Germany.
A summary of the operating results of SSAR for the one-month period ended March
31, 2005, which was included in the results of discontinued operations for
three-months ended March 31, 2005, is as follows:
Revenues $ 14.0
- ---------------------------------------------------------------------
Earnings before income taxes $ 1.2
Income tax expense 0.7
- ---------------------------------------------------------------------
Earnings from discontinued operations $ 0.5
- ---------------------------------------------------------------------
The assets and liabilities of SSAR included in the March 31, 2005 consolidated
balance sheet are comprised of:
- --------------------------------------------------------------------------
Accounts receivable $ 20.5
Inventories 16.4
Property, plant and equipment 34.6
Other assets and intangibles 73.1
- --------------------------------------------------------------------------
Assets held for sale $ 144.6
- --------------------------------------------------------------------------
Accounts payable $14.3
Accrued liabilities and other current liabilities 6.8
Other liabilities 14.4
- --------------------------------------------------------------------------
Liabilities held for sale $ 35.5
- --------------------------------------------------------------------------
5. STOCK-BASED COMPENSATION
The Company accounts for its stock-based compensation under the recognition and
measurement principles of APB No. 25 and related Interpretations. No stock-based
compensation cost is reflected in net earnings for stock options, as all stock
options granted had an exercise price equal to the market value of the
underlying common stock on the date of the grant. Compensation cost for
restricted stock is recorded based on the market value on the date of grant, and
compensation cost for performance stock is recorded based on the quoted market
price of the Company's common stock at the end of each period through the date
of vesting. The fair value of restricted and performance stock is charged to
unearned compensation in Stockholders' Equity and amortized to expense over the
requisite vesting periods. Stock appreciation rights ("SARS") are accounted for
as a liability under APB No. 25 and are payable in cash. Compensation cost for
SARS is recognized in the statement of operations over the vesting period and
through the life of the award based on changes in the current market price of
the Company's common stock over the market price at the grant date.
The following table illustrates the effect on net earnings and net earnings per
share if the Company had applied the fair value recognition provisions of
Statement of Financial Accounting Standards No. 123, "Accounting for Stock-Based
Compensation," to all stock-based employee compensation for the three months
ended March 31:
- --------------------------------------------------------------------------------------------------------
Three Months Ended
March 31,
2005 2004
- --------------------------------------------------------------------------------------------------------
Net earnings (loss) as reported or restated $ (6.5) $ 33.2*
Add:
Stock-based employee compensation expense
included in reported net earnings (loss), net of
related tax effects 0.5 0.3
Deduct:
Total stock-based employee compensation expense
determined under fair-value-based method for all
awards, net of related tax effects 1.9 1.8
- --------------------------------------------------------------------------------------------------------
Pro forma net earnings (loss) $(7.9) $31.7
- --------------------------------------------------------------------------------------------------------
Net earnings (loss) per share:
Basic, as reported or restated $(0.16) $0.85*
Basic, pro forma $(0.19) $0.81
Diluted, as reported or restated $(0.16) $0.83*
Diluted, pro forma $(0.19) $0.79
- --------------------------------------------------------------------------------------------------------
* 2004 results were restated to show the effect of FSP 106-2, which was adopted
retroactively during the third quarter of 2004, and the retroactive application
of the change from the LIFO to the FIFO inventory method which was adopted on
January 1, 2005. Refer to Note 1.
-10-
The fair value of each stock option granted before January 1, 2005 was estimated
on the date of grant using the Black-Scholes option pricing model with the
following weighted average assumptions for the quarter ended March 31, 2004:
2004
- -----------------------------------------------------------
Expected life (years) 5.7
Expected volatility 46.7%
Expected dividend yield 1.0%
Risk-free interest rate 3.4%
Weighted average fair value per option $16.19
- -----------------------------------------------------------
For stock options granted after January 1, 2005, the fair value of each option
award is estimated on the date of grant using a binomial-lattice option
valuation model. The binomial-lattice model considers characteristics of fair
value option pricing that are not available under the Black-Scholes model.
Similar to the Black-Scholes model, the binomial model takes into account
variables such as volatility, dividend yield rate, and risk free interest rate.
However, in addition, the binomial model considers the contractual term of the
option, the probability that the option will be exercised prior to the end of
its contractual life, and the probability of termination or retirement of the
option holder in computing the value of the option. For these reasons, the
Company believes that the binomial-lattice model provides a fair value that is
more representative of actual experience and future expected experience than the
value calculated in previous years, using Black-Scholes. The assumptions for the
quarter ended March 31, 2005 are noted in the following table:
2005
- -----------------------------------------------------------------
Expected life (years) 5.8
Expected volatility 38.5%
Expected dividend yield 0.84%
Range of risk-free interest rate 2.1% - 4.2%
Weighted average fair value per option $17.78
- -----------------------------------------------------------------
6. EARNINGS (LOSS) PER SHARE (EPS)
Basic earnings (loss) per common share excludes dilution and is computed by
dividing net earnings (loss) by the weighted-average number of common shares
outstanding (which includes shares outstanding, less performance and restricted
shares for which vesting criteria have not been met) plus deferred stock awards,
weighted for the period outstanding. Diluted earnings per common share is
computed for the three months ended March 31, 2004 by dividing net earnings by
the sum of the weighted-average number of common shares outstanding for the
period adjusted (i.e., increased) for all additional common shares that would
have been outstanding if potentially dilutive common shares had been issued and
any proceeds of the issuance had been used to repurchase common stock at the
average market price during the period. The proceeds are assumed to be the sum
of the amount to be paid to the Company upon exercise of options, the amount of
compensation cost attributed to future services and not yet recognized and the
amount of income taxes that would be credited to or deducted from capital upon
exercise. For the quarter ended March 31, 2005, all per share calculations are
performed using the same denominator utilized in calculating basic loss from
continuing operations.
The following shows the reconciliation of weighted average shares:
Three Months Ended
March 31,
---------------------------------
2005 2004
---------------- ---------------
Weighted average shares outstanding: 42,118,580 39,098,953
Effect of dilutive shares:
Options -* 914,323
Performance/Restricted Stock -* 86,690
- -----------------------------------------------------------------------------
Adjusted average shares outstanding 42,118,580 40,099,966
- -----------------------------------------------------------------------------
* As of March 31, 2005, 5,488,205 stock options and 180,053 of performance and
restricted shares were outstanding and excluded from the loss per share
calculations.
7. INVENTORIES
Effective January 1, 2005, the Company changed its inventory costing method for
U.S. inventories from the LIFO method to the FIFO method. Refer to Note 1.
-11-
Inventories, as restated, consisted of the following:
- -----------------------------------------------------------------------
March 31, December 31,
2005 2004
- -----------------------------------------------------------------------
Finished goods $ 333.2 $ 165.0
Work in process 33.1 20.6
Raw materials & supplies 150.4 78.2
----------------- -----------------
Total inventories $ 516.7 $ 263.8
- -----------------------------------------------------------------------
8. EQUITY IN EARNINGS OF ASSOCIATED COMPANIES AND MINORITY INTERESTS
Upon acquisition of Surface Specialties, Cytec acquired a 50% ownership interest
in SK Cytec Co., Ltd., a joint venture that manufacturers and sells similar
products to those sold by Surface Specialties. The operations of SK Cytec Co.,
Ltd. are not material to the operations of the Company. At March 31, 2005, the
Company had one associated company that was material to its operations, CYRO
Industries ("CYRO"), a 50% owned joint venture. In April 2005, the Company
announced that it had reached a definitive agreement to sell its 50% ownership
in CYRO to its joint venture partner Degussa Specialty Polymers, a company of
Degussa AG, for cash consideration of $95 million. The proceeds of this
transaction are expected to essentially recover the carrying value of Cytec's
investment in CYRO. The transaction is expected to be completed on May 31, 2005
and is subject to customary closing conditions. The net after-tax proceeds
realized from the sale of CYRO will be used to reduce acquisition-related debt.
Summarized financial information for the Company's equity in earnings of CYRO
for the three months ended March 31 is as follows:
Three Months Ended
March 31,
------------------------------
2005 2004
------------- ------------
Net sales $ 89.8 $ 72.4
Gross profit $ 15.5 $ 9.7
Net earnings $ 6.4 $ 0.6
Equity in earnings of associated company $ 2.1 $ 0.3
The Company sells certain products to CYRO and has determined that the sales and
related profit are immaterial; therefore, no adjustments were made to eliminate
such profit or loss on sales to CYRO for inventory held at the balance sheet
dates.
Upon acquisition of Surface Specialties, Cytec also acquired ownership interests
in two majority-owned entities for which the net assets and results of
operations are consolidated. The earnings associated with the minority ownership
interests are included in other income (expense), net and amount to $0.1 as of
March 31, 2005. The minority ownership interests in the net assets of these
entities are included in other noncurrent liabilities and total $1.7 as of March
31, 2005.
9. DEBT
On March 1, 2005, the Company funded a majority of the purchase price of the
Surface Specialties acquisition with bank debt. The Company borrowed $725.0
under its unsecured five-year term loan facility and $600.0 under its unsecured
364-day credit facility both at interest rates based on a floating LIBOR rate
plus an applicable margin which is based on the Company's credit rating and is
subject to change. The $725.0 facility requires a payment of the lesser of $72.5
or the then outstanding balance each December from 2005 through 2008 with a
final payment due February 2010. Any amounts outstanding under the $600.0
facility at maturity are due and payable at that time. The Company has a $350.0
unsecured five-year revolving credit agreement in place which was undrawn at
March 31, 2005.The facilities contain covenants that are customary for such
facilities.
On February 28, 2005, the Company entered into a cross currency rate swap to
effectively convert $950.0 of the $1,325.0 of U.S. dollar denominated bank debt
to euro denominated debt. This swap, which matured on April 1, 2005, was used as
a natural hedge of the foreign exchange impact on the euro denominated
intercompany loans that the Company acquired as part of the acquisition of
Surface Specialties. Mark-to-market gains or losses on the swap from changes in
the value of the euro are included in the statement of operations and offset the
corresponding losses or gains on the intercompany loans. On the maturity date of
the swap, the Company converted $904.0 of its U.S. dollar denominated bank
borrowings into euro denominated bank borrowings which maintained the natural
hedge on the euro denominated intercompany loans. The weighted-average interest
rate on the acquisition-related debt facilities was 3.79% during the quarter
ended March 31, 2005.
-12-
On March 31, 2005, the Company repaid $20.0 of the 364-day credit facility.
Short-term borrowings at March 31, 2005 include the remaining balance owed under
the 364-day credit facility.
In order to take advantage of current interest rates, the Company elected to
redeem the Mandatory Par Put Remarketed Securities ("MOPPRS") in May, 2005, at
the optional redemption price of $141.0. The optional redemption price
represents the $120.0 principal amount of the securities and a $21.0 pre-tax
interest charge for redemption prior to their final maturity. The redemption
provides the Company with the ability to refinance this debt at a lower cost and
a shorter tenor. Due to this redemption, the Company will also recognize
additional interest expense of $1.0 from amounts related to the unamortized put
premium and rate lock agreements for these securities. The total expense of
$22.0 will be recorded in the second quarter. The $350.0 unsecured five-year
revolving credit facility will be used to fund a majority of the redemption of
the MOPPRS on May 11, 2005 and as such, the MOPPRS are included in long-term
debt at March 31, 2005.
Long-term debt, including the current portion, consisted of the following:
March 31, 2005
-----------------------------
Carrying
Face Value
--------------- -------------
Five-Year Term Loan Due February 14, 2010 $725.0 $725.0
6.75% Notes Due March 15, 2008 100.0 98.4
6.846% Mandatory Par Put Remarketed Securities 120.0 119.0
4.60% Notes Due July 1, 2013 200.0 201.8
Other 22.0 22.1
--------------- -------------
1,167.0 1,166.3
Less: Current maturities 84.9 84.9
--------------- -------------
Long-term debt $1,082.1 $1,081.4
- --------------------------------------------------------------------------------------------------
Upon acquisition of Surface Specialties, the Company assumed the borrowings at
various locations with a face value of $52.7 and a fair value of $52.3. The
table above includes that portion characterized as long-term debt including
current maturities, which totals $22.1.
10. CONTINGENCIES AND COMMITMENTS
Environmental Matters
The Company is subject to substantial costs arising out of environmental laws
and regulations, which include obligations to remove or limit the effects on the
environment of the disposal or release of certain wastes or substances at
various sites or to pay compensation to others for doing so.
As of March 31, 2005 and December 31, 2004, the aggregate environmental related
accruals were $109.5 and $70.7, respectively. The increase primarily relates to
the preliminary estimate of liabilities assumed upon acquisition of Surface
Specialties related to certain sites for which remediation is required. As of
March 31, 2005 and December 31, 2004, $10.0 of the above amounts was included in
accrued expenses, with the remainder included in other noncurrent liabilities.
Environmental remediation spending for the three months ended March 31, 2005 and
2004 was $1.2 and $1.1, respectively.
These accruals can change substantially due to such factors as additional
information on the nature or extent of contamination, methods of remediation
required, changes in the apportionment of costs among responsible parties and
other actions by governmental agencies or private parties or if the Company is
named in a new matter and determines an accrual needs to be provided for or if
the Company determines it is not liable and no longer requires an accrual.
A further discussion of environmental matters can be found in Note 10 of the
Notes to the Consolidated Financial Statements contained in the Company's 2004
Annual Report on Form 10-K.
Other Contingencies
The Company is the subject of numerous lawsuits and claims incidental to the
conduct of its or certain of its predecessors' businesses, including lawsuits
and claims relating to product liability, personal injury including asbestos,
environmental, contractual, employment and intellectual property matters.
-13-
As of March 31, 2005 and December 31, 2004, the aggregate self-insured and
insured contingent liability was $68.9 and $68.4, respectively, and the related
insurance receivable was $39.8 at March 31, 2005 and $37.9 at December 31, 2004.
The asbestos liability included in the above amounts at March 31, 2005 and
December 31, 2004 was $50.3 and $50.4, respectively, and the related insurance
receivable was $34.5 at March 31, 2005 and $34.2 at December 31, 2004. The
Company anticipates receiving a net tax benefit for payment of those claims to
which full insurance recovery is not realized.
The following table presents information about the asbestos claims against the
Company:
Three Months Ended Year Ended
March 31, December 31,
2005 2004
----------------------- ------------------
Number of claimants associated with claims closed during period 1,651 3,540
Number of claimants associated with claims opened during period 318 4,532
Number of claimants at end of period 26,614 27,947
- -------------------------------------------------------------------------------------------------------------------
It should be noted that the ultimate liability and related insurance recovery
for all pending and anticipated future claims cannot be determined with
certainty due to the difficulty of forecasting the numerous variables that can
affect the amount of the liability and insurance recovery. These variables
include but are not limited to: (i) significant changes in the number of future
claims; (ii) significant changes in the average cost of resolving claims; (iii)
changes in the nature of claims received; (iv) changes in the laws applicable to
these claims; and (v) financial viability of co-defendants and insurers.
The Company is among several defendants in approximately 30 cases, in which
plaintiffs assert claims for personal injury, property damage, and other claims
for relief relating to lead pigment that was used as an ingredient decades ago
in paint for use in buildings. The different suits were brought by government
entities and/or individual plaintiffs, on behalf of themselves and others. The
suits variously seek compensatory and punitive damages and/or injunctive relief,
including funds for the cost of monitoring, detecting and removing lead based
paint from buildings and for medical monitoring; for personal injuries allegedly
caused by ingestion of lead based paint; and plaintiffs' attorneys' fee. The
Company believes that the suits are without merit and is vigorously defending
against all such claims. Accordingly, no loss contingency has been recorded. The
Company has access to a substantial amount of primary and excess general
liability insurance for property damage and believes these policies are
available to cover a significant portion of both its defense costs and indemnity
costs, if any, for lead pigment-related property damage claims.
The Company reached an agreement in March 2005 with one of its insurers
regarding the payment of past and future defense costs associated with the lead
pigment litigation. During the first quarter of 2005, the Company recorded $1.3
in other income (expense), net, related to the recovery of past defense costs
under this agreement.
In the first quarter of 2005, the Company increased its reserves by $4.4 as a
result of its agreement in principle to settle claims by a third party for the
costs of environmental remediation at a manufacturing site operated by the
former American Cyanamid Company ("Cyanamid") prior to 1944. In connection with
the Company's 1993 spin-off from Cyanamid, the Company agreed to indemnify
Cyanamid for claims of this nature. Under the terms of the settlement, the third
party will release all claims and indemnify the Company against third-party
environmental remediation claims arising from the alleged contamination at the
site. Although the Company believed it had meritorious defenses to this claim,
the Company agreed to the settlement to avoid incurring additional legal fees
and any risk of an adverse outcome in any related litigation.
While it is not feasible to predict the outcome of all pending environmental
matters, lawsuits and claims, it is reasonably possible that there will be a
necessity for future provisions for costs for environmental matters and for
other contingent liabilities that in management's opinion, will not have a
material adverse effect on the consolidated financial position of the Company,
but could be material to the consolidated results of operations or cash flows of
the Company in any one accounting period. The Company cannot estimate any
additional amount of loss or range of loss in excess of the recorded amounts.
Moreover, many of these liabilities are paid over an extended period, and the
timing of such payments cannot be predicted with any certainty.
From time to time the Company is also included in legal proceedings as a
plaintiff involving tax, contract, patent protection, environmental and other
legal matters. Gain contingencies, if any, are recorded when they are realized.
A further discussion of other contingencies can be found in Note 10 of the Notes
to the Consolidated Financial Statements contained in the Company's 2004 Annual
Report on Form 10-K.
Commitments
The Company frequently enters into long-term contracts with customers with terms
that vary depending on specific industry practices. The Company's business is
not substantially dependent on any single contract or any series of related
contracts. Descriptions of the Company's significant sales contracts at year end
are set forth in Note 10 of the Notes to Consolidated Financial Statements
contained in the Company's 2004 Annual Report on Form 10-K.
-14-
11. COMPREHENSIVE INCOME
The components of comprehensive income, which represents the change in equity
from non-owner sources, for the three months ended March 31, are as follows:
Three Months Ended
March 31,
-----------------------------------
2005 2004
---------------- ---------------
Net (loss) earnings as reported or restated * $ (6.5) $ 33.2
Other comprehensive income (loss):
Unrealized gains on cash flow hedges 1.6 0.2
Foreign currency translation adjustments (8.6) (8.2)
----------- -----------
Comprehensive income $ (13.5) $ 25.2
- ---------------------------------------------------------------------------------------------
* 2004 results were restated to show the effect of FSP 106-2, which was adopted
retroactively during the third quarter of 2004, and the retroactive application
of the change from the LIFO to the FIFO inventory method which was adopted on
January 1, 2005. Refer to Note 1.
12. INCOME TAXES
The Company's effective tax rate on loss from continuing operations for the
three months ended March 31, 2005 was a tax benefit of 66%. For the three months
ended March 31, 2004, the effective tax rate was a tax provision of 24%. The
Company's effective tax rate for the first quarter of 2005 was favorably
impacted by U.S. hedging losses and a reduction in tax expense due to resolution
of the IRS audits discussed below and was unfavorably impacted by the write-off
of acquired in-process research and development expenses related to the Surface
Specialties acquisition, for which there is no tax benefit. The Company's
underlying effective tax rate for the three months ended March 31, 2005 was 27%
excluding these items.
In January, 2005, the Company received notice that the Congressional Joint
Committee on Taxation (the "Joint Committee") approved the final IRS examination
findings for the years 1999 through 2001 and a separate tax refund claim filed
by the Company for 1998. Such Joint Committee approval resulted in a tax refund
of approximately $0.2 and $0.1 for the years 1998 and 2000 respectively, which
was recorded in the first quarter of 2005. The Company also recorded a reduction
in tax expense of approximately $16.2 for the three months ended March 31, 2005
to reflect the final resolution of these audits.
13. OTHER FINANCIAL INFORMATION
On January 20, 2005 the Board of Directors declared a $0.10 per common share
cash dividend, paid on February 25, 2005 to shareholders of record as of
February 10, 2005. Cash dividends paid in the first quarter of 2005 and 2004
were $4.0 and $3.9, respectively. On April 21, 2005 the Board of Directors
declared a $0.10 per common share cash dividend, payable on May 25, 2005 to
shareholders of record as of May 10, 2005.
Taxes paid for the three months ended March 31, 2005 and 2004 were $17.9 and
$1.3, respectively. Interest paid for the three months ended March 31, 2005 and
2004 was $8.4 and $4.4, respectively.
Included in due from related party on the accompanying balance sheet are certain
tax reimbursements to be received from UCB in accordance with the terms of the
purchase agreement entered into in connection with the acquisition of Surface
Specialties. Included in accrued expenses are immaterial amounts due to UCB
under certain transition services agreements.
14. SEGMENT INFORMATION
Effective with the acquisition of Surface Specialties, the Company realigned its
organizational and reporting structure, as discussed in Note 2. In accordance
with SFAS No. 131, "Disclosures About Segments of an Enterprise and Related
Information," the following tables disclose net sales and earnings under the new
reporting structure for all periods presented. The total assets of the Cytec
Surface Specialties segment includes the assets acquired on February 28, 2005
(refer to Note 2). Also total assets of $249.1 were transferred to the Cytec
Performance Specialties segment on January 1, 2005.
-15-
Summarized segment information for the Company's four segments for the three
months ended March 31 is as follows:
2005 2004
- ---------------------------------------------------------------------------------------------------
Net Sales:
Cytec Performance Specialties
Sales to external customers $ 173.4 $ 156.6
Intersegment sales 1.1 1.3
Cytec Surface Specialties 190.8 75.7
Cytec Engineered Materials 127.8 120.3
Building Block Chemicals
Sales to external customers 71.9 62.6
Intersegment sales 23.2 19.3
Net sales from segments 588.2 435.8
Elimination of intersegment revenue (24.3) (20.6)
----------- -----------
Total consolidated net sales $ 563.9 $ 415.2
- ---------------------------------------------------------------------------------------------------
% of % of
Sales Sales
--------------------------------------------------------------------------------------------------------------
Earnings (loss) from operations:
Cytec Performance Specialties $ 14.2 8% $ 9.5 6%
Cytec Surface Specialties (34.5) (18)% 8.6 11%
Cytec Engineered Materials 23.4 18% 23.5 20%
Building Block Chemicals 7.3 8% 6.9 8%
------------------ -----------------
Earnings from segments 10.4 2% 48.5 11%
Corporate and Unallocated (3.3) (1.8)
------------------ -----------------
Total consolidated earnings from operations $ 7.1 1 % $ 46.7 11%
--------------------------------------------------------------------------------------------------------------
15. GOODWILL AND OTHER ACQUISITION INTANGIBLES
The following is the activity in the goodwill balances for each segment. The
2004 beginning balances have been restated to reflect the new organizational
structure referred to in Note 1:
Cytec Cytec Surface Cytec Corporate Total
Performance Engineered
Specialties Specialties Materials
- --------------------------------------------------------------------------------------------------------------------------
Balance, December 31, 2004 $ 63.6 $ 30.7 $ 247.4 $ 0.7 $ 342.4
2005 Acquisition (Note 2) - 671.1 - - 671.1
Currency exchange (1.0) (1.5) - - (2.5)
Other - - (6.3) - (6.3)
---------------------------------------------------------------------------------------
Balance, March 31, 2005 $62.6 $ 700.3 $241.1 $0.7 $ 1,004.7
- --------------------------------------------------------------------------------------------------------------------------
The Company recorded a reduction to goodwill of $6.3 as a result of the
favorable resolution of a tax contingency related to an acquisition that
occurred in a prior reporting period.
Other acquisition intangibles as of March 31, 2005 and December 31, 2004,
consisted of the following major classes:
Weighted Accumulated
Average Gross carrying value amortization Net carrying value
Useful Life
-------------------------------------------------------------------------------------------
March 31, December 31, March 31, December 31, March 31, December 31,
(years) 2005 2004 2005 2004 2005 2004
--------------------------------------------------------------------------------------------------------
Technology-based 15.3 $53.5 $42.5 $(12.7) $(12.2) $40.8 $30.3
Marketing-related 15.4 62.5 11.6 (4.4) (4.0) 58.1 7.6
Marketing-related indefinite 45.7 - - - 45.7 -
Customer-related 15.0 418.7 35.8 (8.6) (6.9) 410.1 28.9
--------------------------------------------------------------------------------------------------------
Total $580.4 $89.9 $(25.7) $(23.1) $554.7 $66.8
- --------------------------------------------------------------------------------------------------------------------------------
Amortization of acquisition intangibles for the three months ended March 31,
2005 and 2004 was $4.0 and $1.4, respectively. Amortization expense for the
three months ended March 31, 2005 includes one month of amortization of the
acquisition intangibles associated with the Company's purchase of Surface
Specialties. Assuming no change in the gross carrying amount of acquisition
intangibles, the estimated amortization of acquisition intangibles for the
fiscal year 2005 is $30.0 and for the years 2006 through 2009 is $36.0 per year.
Included in marketing-related intangibles is $45.7 relating to certain
tradenames purchased upon acquisition of Surface Specialties which have
indefinite useful lives.
-16-
16. COMMODITY AND DERIVATIVE FINANCIAL INSTRUMENTS
At March 31, 2005, the Building Block Chemicals segment Fortier plant's 2005
remaining forecasted natural gas utility requirements were 64% hedged utilizing
natural gas forward contracts. These contracts have delivery dates ranging from
April, 2005 to December, 2005. Additionally, the plant's 2006 gas utility
requirements were 4% hedged at March 31, 2005, and these contracts have delivery
dates ranging from January to March 2006.
At March 31, 2005, the Company held natural gas swaps with a favorable fair
value of $1.1, net of taxes, which will be reclassified into Manufacturing Cost
of Sales through March 2006 as these swaps are settled.
The Company has engaged in currency and interest rate hedging activities in
connection with the acquisition of Surface Specialties and related financing.
Refer to Notes 2 and 9.
For more information regarding the Company's hedging activities and derivative
financial instruments, refer to Note 4 to the Consolidated Financial Statements
contained in the Company's 2004 Annual Report on Form 10-K.
17. EMPLOYEE BENEFIT PLANS
Net periodic cost for the Company's pension and postretirement benefit plans was
as follows:
Pension Plans Postretirement Plans
--------------------------------- -----------------------------
Three Months Ended March 31,
----------------------------------------------------------------------
2005 2004 2005 2004*
----------------------------------------------------------------------------------------------------------
Service cost $ 4.5 $ 3.7 $ 0.3 $ 1.0
Interest cost 9.7 8.7 3.6 14.2
Expected return on plan assets (10.0) (9.4) (1.3) (5.0)
Net amortization and deferral 2.8 1.6 (2.7) (10.6)
----------- ----------- ------------ ----------
Net periodic cost $ 7.0 $ 4.6 $ (0.1) $ (0.4)
----------------------------------------------------------------------------------------------------------
* 2004 amounts were restated to show the effect of FSP 106-2, which was adopted
retroactively during the third quarter of 2004. Refer to Note 1.
The Company disclosed in its annual report on Form 10-K for the year ended
December 31, 2004, that it expected to contribute $15.8 and $20.5, respectively,
to its pension and postretirement plans in 2005. Through March 31, 2005, $6.4
and $4.6 in contributions were made, respectively. The Company makes these
voluntary contributions as a part of its normal financial planning. In
conjunction with the acquisition, the Company is in the process of evaluating
its pension and post-retirement plans and related funding requirements and, as
such, contributions relating to the acquired businesses have not been included
in contributions amounts discussed above.
The Company also sponsors various defined contribution retirement plans in the
United States and a number of other countries, consisting primarily of savings
and profit growth sharing plans. Contributions to the savings plans are based on
matching a percentage of employees' contributions. Contributions to the profit
growth sharing plans are generally based on the Company's financial performance.
Amounts expensed related to these plans for the three months ended March 31,
2005 and 2004 were $4.8 and $4.0, respectively.
-17-
Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
OF OPERATIONS
The following discussion and analysis should be read in conjunction with the
Consolidated Financial Statements and Notes to Consolidated Financial
Statements. Dollars are in millions, except per share amounts. Percentages are
approximate.
GENERAL
Cytec Industries Inc. is a global specialty chemicals and materials company and
sells its products to diverse major markets for aerospace, automotive and
industrial coatings, chemical intermediates, mining, plastics and water
treatment. Sales volume by region and the impact of exchange rates are important
measures that are analyzed by management.
On February 28, 2005, the Company completed its acquisition of the Surface
Specialties business of UCB Group. The acquisition was recorded using the
purchase method of accounting. Accordingly, the results of operations of Surface
Specialties have been included in the Company's consolidated results from the
date of acquisition. A further discussion of the acquisition of Surface
Specialties can be found in Note 2 to the Notes to the Consolidated Financial
Statements contained herein.
The Company also realigned the organizational structure of its four reportable
segments. Cytec Performance Specialties now includes the following product
lines: Water Treatment Chemicals, Mining Chemicals, Phosphine and Phosphorus
Derivatives, Polymer Additives and Specialty Additives. Cytec Surface
Specialties now includes the following product lines: the acquired Surface
Specialties business plus the previously existing Coating Chemicals and
Performance Chemicals product lines. Specialty Materials has been renamed Cytec
Engineered Materials and there is no change to Building Block Chemicals. The
Cytec Performance Specialties and Cytec Surface Specialties segments are
collectively referred to as Specialty Chemicals. The Company also reports its
net sales in four geographic regions: North America, Latin America, Asia/Pacific
and Europe/Middle East/Africa. The destination of the sale determines the region
under which it is reported consistent with management's view of the business.
North America consists of the United States and Canada. Latin America includes
Mexico, Central America, South America and the Caribbean Islands. Asia/Pacific
is comprised of Asia, Australia and the islands of the South Pacific Rim.
Raw material cost changes year on year are an important factor in profitability
especially in years of high volatility. Oil and natural gas costs are
significantly higher than the year ago period and many of the Company's raw
materials are derived from these two commodities. Key raw materials for the
Specialty Chemicals and Building Block Chemicals segments are propylene,
ammonia, methanol derivatives, acrylic acid and natural gas for utilities. Key
raw materials for the Cytec Engineered Materials segment are carbon fiber and
various resins. Discussion of the year to year impact of raw materials and
energy is provided in our segment discussion. In addition, higher global demand
levels and, occasionally, operating difficulties at suppliers, have limited the
availability of certain of the Company's raw materials. Effective February 1,
2005, the Company's major supplier of propylene placed the Company on an 85%
supply allocation of its requirements for up to six months due to mechanical
difficulties. This allocation did not impact Company operations in the first
quarter of 2005 as the Company procured adequate quantities of propylene from
other suppliers to meet customer demand and to operate its plant at desired
capacity. The Company expects normal supply to resume in the second quarter of
2005.
QUARTER ENDED MARCH 31, 2005, COMPARED WITH QUARTER ENDED MARCH 31, 2004
Consolidated Results
Net sales for 2005 were $563.9 compared with $415.2 during 2004. All segments
reported increased sales. In the Cytec Surface Specialties segment, sales
increased primarily as a result of the inclusion of one month of sales of
Surface Specialties which was acquired on February 28, 2005. The Cytec
Performance Specialties segment experienced increased sales which were due in
part to increased volumes as well as price increase initiatives. The Cytec
Engineered Materials segment sales increase was volume related, primarily from
increased sales to the commercial aircraft and rotorcraft sectors. The Building
Block Chemicals segment sales increased principally due to higher selling prices
which were driven by higher raw material and energy costs offset somewhat by a
decrease in sales volumes of acrylonitrile and acrylamide.
For a detailed discussion on sales refer to the Segment Results section below.
Manufacturing cost of sales was $440.3 compared with $310.1 during 2004. Most of
the increase is associated with higher volumes, principally resulting from the
impact of the acquisition of Surface Specialties. Cost of sales was impacted by
higher raw material and energy costs of $24.0. The higher raw material and
energy costs were offset by increased selling prices of $23.9. Gross margin was
negatively impacted by increased plant spending and manufacturing difficulties
experienced in the European operations of the Company's engineered materials
-18-
segment and a charge of $10.5 for the amortization of a portion of the write-up
to fair market value for those inventories which were acquired in the
acquisition and subsequently sold to customers. The fair value of the acquired
inventory significantly exceeded normal manufactured cost. Gross margin would
have decreased by 1.5% after exclusion of the inventory charge. A similar charge
is expected to affect gross margin during the second quarter upon sale of the
remaining inventories that were acquired in the acquisition.
Selling and technical services was $44.7 in 2005 versus $34.8 in the prior year.
This increase was primarily attributable to the inclusion of one month of
expenses relating to Surface Specialties with a base increase in same-business
selling and technical services expenses accounting for $2.7 of the increase and
$0.9 resulting from the impact of exchange rates changes during the period.
Research and process development was $13.0 versus $9.0 in the prior year. This
increase was primarily attributable to the inclusion of one month of expenses
relating to Surface Specialties with a base increase in same-business research
and process development expenses accounting for $1.0 of the increase and $0.2
resulting from the impact of exchange rates changes during the period.
Administrative and general expenses were $17.8 versus $13.2 in the prior year.
This increase was primarily attributable to the inclusion of one month of
expenses relating to Surface Specialties.
Amortization of acquisition intangibles was $4.0 versus $1.4 in the prior year.
This increase resulted from the inclusion of one month of amortization expense
relating to the intangibles which resulted from the acquisition of Surface
Specialties.
In connection with the acquisition of Surface Specialties, $37.0 of acquired
in-process research and development costs were expensed.
Other income (expense), net was an expense of $20.3 compared with income of $0.9
in the prior year. Included in the 2005 results was a net loss of $20.0 related
to derivative contracts entered into to hedge currency and interest rate
exposure associated with the acquisition of Surface Specialties. The Company
entered into foreign currency contracts that expired at the acquisition closing
date, to offset the potential dollar to euro exchange rate fluctuation that
would have an impact on the acquisition cost in dollars and this resulted in a
loss of $19.2. In anticipation of future long-term debt that would be issued to
partially finance the acquisition, the Company also entered into interest rate
derivatives which resulted in the recognition of a loss of $0.8. These contracts
mature in June, 2005. Also, in March 2005, the Company reached an agreement with
one of its insurers regarding the payment of past and future defense costs
associated with the lead pigment litigation. During the first quarter of 2005,
the Company recorded $1.3 in other income (expense), net, related to the
recovery of past defense costs under this agreement. Also included is a charge
of $4.4 as a result of an agreement in principle to settle claims by a third
party for the costs of environmental remediation at a manufacturing site
operated by the former American Cyanamid Company prior to 1944.
Equity in earnings of associated companies was $2.1 versus $0.3 in the prior
year due to increased sales volumes. In April 2005, the Company announced that
it has reached a definitive agreement to sell its 50% ownership in CYRO
Industries to its joint venture partner Degussa Specialty Polymers, a company of
Degussa AG, for cash consideration of $95 million. The proceeds of this
transaction are expected to essentially recover the carrying value of Cytec's
investment in CYRO. The transaction is expected to be completed on May 31, 2005
and is subject to customary closing conditions. The net after-tax proceeds
realized from the sale of CYRO will be used to reduce acquisition-related debt.
Interest expense, net was $9.5 compared with $3.8 in the prior year. The
increase resulted primarily from a higher outstanding weighted-average debt
balance during 2005 resulting from the debt incurred in conjunction with the
Company's acquisition of Surface Specialties.
The Company's effective tax rate on loss from continuing operations for the
three months ended March 31, 2005 was a tax benefit of 66%. For the three months
ended March 31, 2004, the effective tax rate was a tax provision of 24%. The
Company's effective tax rate for the first quarter of 2005 was favorably
impacted by U.S. hedging losses and a reduction in tax expense due to resolution
of the IRS audits discussed below and was unfavorably impacted by the write-off
of acquired in-process research and development expenses related to the Surface
Specialties acquisition, for which there is no tax benefit. The Company's
underlying effective tax rate for the three months ended March 31, 2005 was 27%
excluding these items.
Earnings from discontinued operations were $0.5 and reflect the results of SSAR
for the one-month period since acquisition.
Net loss for 2005 was $6.5 ($0.16 net loss per basic and diluted share) compared
with net earnings for 2004 were $33.2 ($0.83 per diluted share). The decrease of
$39.7 in net earnings resulted primarily from the write-off of $37.0 of
in-process research and development costs and the $10.5 amortization charge from
the write-up to fair value of the acquired inventory that was subsequently sold.
These items were partially offset by the impact of increased sales.
-19-
Segment Results
Year-to-year comparisons and analyses of changes in net sales by product line
segment and region are set forth below and reflect the new organizational and
reporting structure of its reportable segments for all periods presented.
Cytec Performance Specialties
% Change Due to
Total ----------------------------------------
2005 2004 % Change Price Volume/Mix Currency
- ---------------------------------------------------------------------------------------------------------------------------------
North America $72.2 $65.2 11% 6% 5% 0%
Latin America 28.2 23.9 18% 7% 10% 1%
Asia/Pacific 23.4 23.3 0% 3% -4% 1%
Europe/Middle East/Africa 49.6 44.2 12% 1% 6% 5%
--------------------------
Total $173.4 $156.6 11% 4% 5% 2%
- ---------------------------------------------------------------------------------------------------------------------------------
Overall selling volume increased 5% and is primarily attributable to increased
sales in the water treating and mining chemicals product lines. On a regional
basis, sales volumes in Latin America increased 10% primarily due to improved
demand for mining chemicals from copper mining applications. Sales volumes were
up 6% in Europe/Middle East/Africa primarily due to increased demand for water
treatment chemicals from full service providers. Overall average price increased
as a result of implementation of price increase initiatives undertaken during
the quarter.
Earnings from operations were $14.2, or 8% of sales, compared with $9.5 or 6% of
sales in 2004. The increase in earnings is primarily attributable to increased
selling volumes and the impact of price increases of $6.9 which more than offset
higher raw material and energy costs of $5.6.
Cytec Surface Specialties
% Change Due to
----------------------------------------
Total Acquisition/
2005 2004 % Change Price Volume Currency
- ---------------------------------------------------------------------------------------------------------------------------------
North America $62.0 $37.6 65% 2% 63% 0%
Latin America 8.1 4.7 72% 2% 68% 2%
Asia/Pacific 30.4 14.3 113% 0% 109% 4%
Europe/Middle East/Africa 90.3 19.1 373% 2% 365% 6%
--------------------------
Total $190.8 $75.7 152% 1% 149% 2%
- ---------------------------------------------------------------------------------------------------------------------------------
For all regions, selling volumes increased 149% primarily as a result of the
inclusion of sales attributable to Surface Specialties which was acquired on
February 28, 2005 with base volumes accounting for 1%. In North America and
Latin America, all of the volume increase is acquisition related. In
Asia/Pacific, base business grew 10% with the remainder resulting from the
acquisition. In Europe/Middle East/Africa, base volumes were down 3% with the
remainder due to the acquisition.
Loss from operations was $34.5, or 18% of sales, compared with earnings from
operations of $8.6, or 11% of sales, in 2004. The decrease in earnings is
primarily attributable to the write-off of in process research and development
costs of $37.0 and a charge of $10.5 for the write-off of manufacturing profit
included in the inventories which were acquired in the acquisition.
Cytec Engineered Materials
% Change Due to
Total ----------------------------------------
2005 2004 % Change Price Volume/Mix Currency
- ---------------------------------------------------------------------------------------------------------------------------------
North America $81.6 $80.8 1% 0% 1% 0%
Latin America(1) 0.5 0.4 --- --- --- ---
Asia/Pacific 6.6 4.5 47% -2% 49% 0%
Europe/Middle East/Africa 39.1 34.6 13% 0% 12% 1%
------------- ------------
Total $127.8 $120.3 6% 0% 6% 0%
- ---------------------------------------------------------------------------------------------------------------------------------
(1) Due to the level of sales in this geographic region, percentage comparisons
are not meaningful.
Overall selling volumes increased 6%. Asia/Pacific and Europe/Middle East/Africa
sales volumes increased 49% and 12%, respectively, with the increases coming
from the large commercial aircraft and rotorcraft industries.
-20-
Earnings from operations were $23.4, or 18% of sales, compared with $23.5, or
20% of sales, in 2004. The impact of the increased sales on operating earnings
was offset by manufacturing difficulties in Europe plus increased selling and
research costs as the Company continues to invest in the future.
Building Block Chemicals (Sales to external customers)
% Change Due to
Total ----------------------------------------
2005 2004 % Change Price Volume/Mix Currency
- ---------------------------------------------------------------------------------------------------------------------------------
North America $ 42.5 $ 30.7 38% 28% 10% 0%
Latin America(1) 1.2 0.6 --- --- --- ---
Asia/Pacific 18.1 18.5 -2% 29% -31% 0%
Europe/Middle East/Africa 10.1 12.8 -21% 13% -38% 4%
-------------- ------------
Total $71.9 $62.6 15% 25% -11% 1%
- ---------------------------------------------------------------------------------------------------------------------------------
(1) Due to the level of sales in this geographic region, percentage comparisons
are not meaningful.
Sales are higher overall due to higher selling prices, primarily for
acrylonitrile, and were in line with the increase in raw material costs. Selling
volumes decreased 11% overall, primarily as a result of a decrease in demand for
acrylonitrile to customers in the Asia/Pacific and Europe/Middle East/Africa
regions. Additionally, acrylamide sales declined in the Europe/Middle
East/Africa region as a result of reduced demand and loss of a certain customer.
North America selling volumes were up 10% with the majority due to increased
acrylonitrile sales resulting from new business.
Earnings from operations were $7.3, or 8% of sales, compared with $6.9, or 8% of
sales, in 2004. The increase in earnings was primarily due to improved plant
operations as most of the plant ran at capacity, while in the prior year period,
the acrylonitrile plant ran at a reduced rate due to lower propylene
availability. Increased raw material and energy costs of $15.9, particularly
propylene and natural gas, were essentially offset by higher selling prices of
$15.7.
LIQUIDITY AND FINANCIAL CONDITION
At March 31, 2005 the Company's cash balance was $76.7 compared with $323.8 at
year end 2004. This decrease was primarily attributable to the use of $184.0 in
cash to pay for a portion of the purchase price of Surface Specialties.
Cash flows used in operating activities were $30.6 for 2005 compared with cash
flows provided by operating activities of $22.7 for 2004. Inventory increased by
$21.2 reflecting the higher costs due to increasing raw material costs,
additional purchases made to ensure adequate supply of certain materials, and
the downturn in demand experienced in the latter part of the quarter. Cash flows
from operations include payments of $20.0 for incentive compensation and profit
sharing payouts relating to prior year results which were reflected in accrued
expenses. Cash flows from operations also include payment of $5.0 related to the
currency derivatives entered into in connection with the Surface Specialties
acquisition. Other payments for the quarter include pension and postretirement
plan funding of $11.0. Trade accounts receivable increased by $5.4 reflecting
the increased level of sales experienced during the quarter.
Cash flows used in investing activities were $1,517.8 for 2005 compared with
$7.1 for 2004. This increase was primarily attributable to the acquisition of
Surface Specialties. See below for further discussion. During the first quarter
of 2004, the Company received from a third party $9.1, net of expenses, as a
prepayment for a long-term lease on a certain property for future development.
The development of the property is not connected with Company operations. The
third party has the option to purchase the property from the Company at a later
date. The net proceeds are being amortized to income over the life of the lease.
Capital spending for the 2005 first quarter was $17.1. Capital spending for the
full year is expected to approximate $120.0 as spending increases sequentially
due to certain capacity expansion projects and the addition of Surface
Specialties.
Net cash flows provided by financing activities were $1,307.0 in 2005 compared
with net cash flows used in financing activities of $11.6 during 2004. This
increase primarily resulted from borrowings under the Company's credit
facilities used to purchase Surface Specialties.
On January 20, 2005 the Board of Directors declared a $0.10 per common share
cash dividend, paid on February 25, 2005 to shareholders of record as of
February 10, 2005. Cash dividends paid in the first quarter of 2005 and 2004
were $4.0 and $3.9, respectively. On April 21, 2005 the Board of Directors
declared a $0.10 per common share cash dividend, payable on May 25, 2005 to
shareholders of record as of May 10, 2005.
On February 28, 2005, the Company completed its acquisition of the Surface
Specialties business of UCB, a Belgium biopharmaceutical and specialty chemical
company, for cash and stock valued at $1,799.6 of which $1,508.8 was paid in
cash and the balance was paid in 5,772,857 shares of Cytec common stock ($290.8
at $50.37 per Cytec share, based on the five-day average value of the shares
before and after February 7, 2005, the date on which the terms of the amended
acquisition agreement were announced). In addition, there is contingent
consideration up to a maximum of 50 million euros, of which 20 million euros
-21-
($26.5 at 1.32 US dollar per euro) was paid upon closing, subject to refund, and
is not included in the total consideration of $1,799.6, with the balance
potentially payable in 2006. The contingent consideration is included in other
assets in the accompanying balance sheet and will be earned on a pro-rata basis
pending the achievement of certain full-year operating results by Surface
Specialties in 2005. If the contingent consideration is earned, goodwill would
be increased. The cash purchase price was also preliminarily adjusted as a
result of working capital levels, including cash and certain debt balances which
were transferred to the Company at closing. In addition, $12.0 of transaction
costs were incurred in connection with the acquisition some of which remains
unpaid at March 31, 2005.
The Company financed the cash component with $600.0 under an unsecured 364-day
credit facility, $725.0 under an unsecured five-year term loan and the remaining
$184.0 was paid from existing cash. The Company intends to refinance the 364-day
borrowing with long-term debt. On March 31, 2005, the Company repaid $20.0 of
the 364-day credit facility. Refer to Note 9 in the consolidated financial
statements for other disclosures concerning the Company's debt.
Upon closing, UCB became the owner of approximately 12.5% of the outstanding
shares of the Company. UCB and the Company also entered into a Stockholder's
Agreement which provides, subject to various exceptions, that UCB must reduce
its stake to less than 9% within three years, less than 7% within four years and
less than 5% within five years and which provides that UCB will be prohibited
from purchasing additional shares of Cytec common stock or causing, advocating
or participating in a change in control in the ownership of Cytec. The
Stockholders Agreement also contains customary terms and conditions including an
obligation of UCB to vote its shares of Cytec common stock in accordance with
the Company's Board of Directors' recommendation on certain matters.
The global Surface Specialties business had revenues of approximately $1,350 in
2004 which included approximately $154 of sales from the SSAR product line.
Pursuant to regulatory approvals, the Company is required to divest SSAR by
September, 2005. Until such time as SSAR is sold, results of its operations will
be classified as discontinued operations in the Company's consolidated statement
of operations. The net after-tax proceeds realized from the divestiture of SSAR
will be used to reduce debt. The assets and liabilities of SSAR have been
classified separately in the Company's consolidated balance sheet. Refer to Note
4 in the consolidated financial statements for additional information relating
to discontinued operations.
The Company had previously entered into $623.2 of forward-starting interest rate
swaps to hedge the benchmark interest rate and credit spread on a portion of the
long-term debt that will be issued in 2005 to refinance the bank debt
outstanding under the 364-day credit facility that was drawn for the acquisition
of Surface Specialties. The credit spread portions of the swaps were
representative of AA-rated 10-year notes and served as a proxy credit spread for
the Company. In March 2005, the Company extended the maturity date of $598.2 of
the $623.2 swaps to June 2005. Due to a reduction in borrowing requirements, the
Company liquidated its remaining $25.0 forward starting interest rate swap in
March 2005 at a cost of $0.4. The swaps are being marked to market and recorded
currently in earnings until maturity or settlement. The net pre-tax impact of
the marked to market value on these swaps was a loss of $0.8 which was recorded
in other income (expense), net for the quarter ended March 31, 2005. In the
fourth quarter of 2004, the Company recorded a loss of $6.5 on interest rate
swap transactions entered into in connection with the acquisition.
The Company had also previously entered into foreign currency forward contracts
totaling 1.037 billion euros that related to approximately 87% of the euro
exposure of 1.190 billion for the cash component of the Surface Specialties
acquisition. The forward contracts, which matured on February 28, 2005, were
marked to market and recorded currently in earnings until their maturity. The
impact on earnings for the quarter ended March 31, 2005 of the mark to market
adjustment on these forward contracts was a net pre-tax expense of $19.2 and was
recorded in other income (expense), net. In the fourth quarter of 2004, the
Company recorded a gain of $33.3 on currency forward transactions entered into
in connection with the acquisition.
In connection with the acquisition, the Company suspended its stock buy-back
program and does not anticipate making future stock buy-backs for at least two
years from the closing date in order to maximize the funds available for debt
service and other corporate purposes.
In order to take advantage of current interest rates, the Company elected to
redeem the MOPPRS in May, 2005, at the optional redemption price of $141.0. The
optional redemption price represents the $120.0 principal amount of the
securities and a $21.0 pre-tax interest charge for redemption prior to their
final maturity. The redemption provides the Company with the ability to
refinance this debt at a significantly lower cost and a shorter tenor. Due to
this redemption, the Company will also recognize additional interest expense of
$1.0 from amounts related to the unamortized put premium and rate lock
agreements for these securities. The total expense of $22.0 will be recorded in
the second quarter. The $350.0 unsecured five-year revolving credit facility
will be used to fund a majority of the redemption of the MOPPRS on May 11, 2005
and as such, the MOPPRS are included in long-term debt at March 31, 2005.
-22-
The Company believes that it will be able to fund its operating cash
requirements, planned capital expenditures and dividends from internal cash
generation. Cash realized from the anticipated divestitures of CYRO and SSAR
will be used to reduce acquisition related debt.
The Company has not guaranteed any indebtedness of its unconsolidated associated
companies.
Excluding the impact of increasing raw materials, inflation is not considered
significant since the rate of inflation has remained relatively low in recent
years and investments in areas of the world where inflation poses a risk are
limited. The impact of increasing raw material costs are discussed under
"Customers and Suppliers" in "Business" in Item 1 in the Company's 2004 Annual
Report on Form 10-K.
OTHER
2005 OUTLOOK
In its May 5, 2005 press release, which was also filed as an exhibit to a
current report on Form 8-K, the Company set forth its assumptions and
management's best estimate of the full year 2005 earnings at the time based on
various assumptions set forth in its press release.
The Company's guidance for 2005 outlook will be updated when it reports second
quarter 2005 earnings. There can be no assurance that sales or earnings will
develop in the manner projected. Actual results may differ materially. See
"Comments on Forward Looking Statements."
SIGNIFICANT ACCOUNTING ESTIMATES / CRITICAL ACCOUNTING POLICIES
See "Critical Accounting Policies" under Item 7A of the Company's 2004 Annual
Report on Form 10-K, filed with the Securities and Exchange Commission on
February 25, 2005 and incorporated by reference herein.
In addition to these critical accounting policies, the Company now believes the
application of SFAS No. 141 related to the accounting for business combinations
is critical given the February 28, 2005 acquisition of Surface Specialties and
the ongoing allocation of the purchase price to the fair values of acquired
assets and liabilities assumed.
COMMENTS ON FORWARD-LOOKING STATEMENTS
A number of the statements made by the Company in this report, in the Company's
Annual Report on Form 10-K, or in other documents, including but not limited to
the Chairman, President and Chief Executive Officer's letter to Stockholders,
its press releases and other periodic reports to the Securities and Exchange
Commission, may be regarded as "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, among others, statements concerning the
Company's (including its segments) outlook for the future, anticipated results
of acquisitions and divestitures, pricing trends, the effects of changes in
currency rates and forces within the industry, the completion dates of and
anticipated expenditures for capital projects, expected sales growth,
operational excellence strategies and their results, expected annual effective
tax rates, long-term goals of the Company and other statements of expectations,
beliefs, future plans and strategies, anticipated events or trends and similar
expressions concerning matters that are not historical facts. Such statements
are based upon the current beliefs and expectations of management and are
subject to significant risks and uncertainties. Actual results may vary
materially from those set forth in the forward-looking statements.
The following factors, among others, could affect the anticipated results: the
ability to integrate successfully Surface Specialties, including realization of
anticipated synergies within the expected timeframes or at all, and ongoing
operations of the business; changes in global and regional economies; the
financial well-being of end consumers of the Company's products; changes in
demand for the Company's products or in the quality, costs and availability of
its raw materials and energy; customer inventory reductions; the actions of
competitors; currency and interest rate fluctuations; technological change; the
Company's ability to renegotiate expiring long-term contracts; changes in
employee relations, including possible strikes; government regulations,
including those related to taxation and those particular to the purchase, sale
and manufacture of chemicals or operation of chemical plants; governmental
funding for those military programs that utilize the Company's products;
litigation, including its inherent uncertainty and changes in the number or
severity of various types of claims brought against the Company; difficulties in
plant operations and materials transportation; environmental matters; returns on
employee benefit plan assets and changes in the discount rates used to estimate
employee benefit liabilities; changes in the medical cost trend rate; changes in
accounting principles or new accounting standards; war, terrorism or sabotage;
epidemics; and other unforeseen circumstances.
-23-
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
For a discussion of market risks at year-end, refer to Item 7A of the Company's
Annual Report on Form 10-K for the year ended December 31, 2004, filed with the
Securities and Exchange Commission on February 25, 2005 and incorporated by
reference herein. During 2005, the Company executed various foreign exchange
transactions that do not materially alter the market risk assessment performed
as of December 31, 2004. For a discussion of the currency hedges entered into as
part of the acquisition of Surface Specialties, refer to "Liquidity and
Financial Condition" in Item 2, "Management's Discussion and Analysis of
Financial Condition and Results of Operations." Other 2005 financial instrument
transactions include:
Commodity Price Risk: At March 31, 2005, the Building Block Chemicals segment
Fortier plant's 2005 remaining forecasted natural gas utility requirements were
64% hedged utilizing natural gas forward contracts. These contracts have
delivery dates ranging from April 2005 to December 2005. Additionally, the
plant's 2006 gas utility requirements were 4% hedged at March 31, 2005, and
these contracts have delivery dates ranging from January to March 2006.
At March 31, 2005, the Company held natural gas swaps with a favorable fair
value of $1.1, net of taxes, which will be reclassified into Manufacturing Cost
of Sales through March 2006 as these swaps are settled.
Interest Rate Risk: At March 31, 2005, the outstanding borrowings of the Company
consisted of $613.7 of short-term borrowings and long-term debt, including the
current portion, which had a carrying value of $1,166.3 a face value of $1,167.0
and a fair value, based on dealer quoted values, of approximately $1,148.5.
Assuming other factors are held constant, a hypothetical increase/decrease of 1%
in the weighted average prevailing interest rates on our variable rate debt
outstanding as of March 31, 2005, interest expense would increase/decrease by
approximately $3.4 for the next fiscal quarter.
For a discussion of the interest rate derivative activities entered into as part
of the acquisition of Surface Specialties, refer to "Liquidity and Financial
Condition" in Item 2, "Management's Discussion and Analysis of Financial
Condition and Results of Operations."
Item 4. CONTROLS AND PROCEDURES
As of the end of the period covered by this report, the Company carried out an
evaluation, under the supervision and with the participation of the Company's
management, including the Chief Executive Officer and Chief Financial Officer,
of the effectiveness of the Company's disclosure controls and procedures as
required by Exchange Act Rule 13a-15(b) as of the period ended March 31, 2005.
Based upon that evaluation, the Chief Executive Officer and Chief Financial
Officer have concluded that the Company's current disclosure controls and
procedures are reasonably effective.
The acquisition of Surface Specialties on February 28, 2005 represents a
material change in internal control over financial reporting since management's
last assessment of the effectiveness of the Company's internal controls over
financial reporting which was as of December 31, 2004. The acquired Surface
Specialties businesses utilize separate information and accounting systems and
processes and it was not possible to complete an evaluation and review of the
internal controls over financial reporting since the acquisition was completed.
Management intends to complete its assessement of the effectiveness of internal
controls over financial reporting for the acquired business within one year of
the date of the acquisition.
With the exception of the Surface Specialties acquisition as noted above, there
were no changes in internal controls over financial reporting that occurred
during the first quarter of 2005 that have materially affected, or are
reasonably likely to materially affect, the Company's internal control over
financial reporting.
-24-
PART II - OTHER INFORMATION
Item 1. LEGAL PROCEEDINGS
The Company is the subject of numerous lawsuits and claims incidental to the
conduct of its or its predecessors' businesses, including lawsuits and claims
relating to product liability, personal injury, environmental, contractual,
employment and intellectual property matters. Many of the matters relate to the
use, handling, processing, storage, transport or disposal of hazardous
materials. The Company believes that the resolution of such lawsuits and claims,
including those described below, will not have a material adverse effect on the
consolidated financial position of the Company, but could be material to the
consolidated results of operations and cash flows of the Company in any one
accounting period. The Company, in this section, includes certain predecessor
entities being indemnified by Cytec.
Set forth below are updates to the legal proceedings section found in the
Company's Annual Report on Form 10-K.
The Company reached an agreement in March 2005 with one of its insurers
regarding the payment of past and future defense costs associated with the lead
pigment litigation. During the first quarter of 2005, the Company recorded $1.3
in other income (expense), net, relating to the recovery of past defense costs
related to this agreement.
The following table presents information about the number of claimants involved
in asbestos cases with the Company:
Three Months Ended Year Ended
March 31, December 31,
2005 2004
----------------------- ------------------
Number of claimants associated with claims closed during period 1,651 3,540
Number of claimants associated with claims opened during period 318 4,532
Number of claimants at end of period 26,614 27,947
- -------------------------------------------------------------------------------------------------------------------
In the first quarter of 2005, the Company increased its reserves by $4.4 as a
result of its agreement in principle to settle claims by a third party for the
costs of environmental remediation at a manufacturing site operated by the
former American Cyanamid Company ("Cyanamid") prior to 1944. In connection with
the Company's 1993 spin-off from Cyanamid, the Company agreed to indemnify
Cyanamid for claims of this nature. Under the terms of the settlement, the third
party will release all claims and indemnify the Company against third-party
environmental remediation claims arising from the alleged contamination at the
site. Although the Company believed it had meritorious defenses to this claim,
the Company agreed to the settlement to avoid incurring additional legal fees
and any risk of an adverse outcome in any related litigation.
In addition to liabilities with respect to the specific cases described above,
because the production of certain chemicals involves the use, handling,
processing, storage, transportation and disposal of hazardous materials, and
because certain of the Company's products constitute or contain hazardous
materials, the Company has been subject to claims of injury from direct exposure
to such materials and from indirect exposure when such materials are
incorporated into other companies' products. There can be no assurance that, as
a result of past or future operations, there will not be additional claims of
injury by employees or members of the public due to exposure, or alleged
exposure, to such materials.
See also the Note 10 of the Notes to the Consolidated Financial Statements,
herein.
-25-
Item 2. SALES OF UNREGISTERED SECURITIES AND USE OF PROCEEDS
In connection with the acquisition referred to in Note 2 of the Notes to
Consolidated Financial Statements contained herein, Cytec issued 5,772,857
shares of its common stock (the "Purchase Price Shares") to UCB as partial
consideration for the purchase of Surface Specialties. The Purchase Price Shares
were valued at $290.8 ($50.37 per Cytec share). The issuance of the Purchase
Price Shares was not registered as the transaction was exempt from registration
pursuant to Section 4(2) of the Securities Act of 1933, as amended. In
determining that the Section 4(2) exemption was applicable to the issuance,
Cytec relied on, among other things, UCB's representation that UCB was acquiring
the Purchase Price Shares for investment purposes and not with a view toward any
distribution thereof, or with any present intention of distributing the Purchase
Price Shares other than as provided in the Stockholder's Agreement.
-26-
Item 6. EXHIBITS
(a). Exhibits
See Exhibit Index on page 29 for exhibits filed with this Quarterly Report on
Form 10-Q.
-27-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
CYTEC INDUSTRIES INC.
By: /s/ James P.Cronin
----------------------
James P. Cronin
Executive Vice President and
Chief Financial Officer
May 10, 2005
-28-
Exhibit Index
-------------
12 Computation of Ratio of Earnings to Fixed Charges for the three and three months ended March 31, 2005 and
2004.
18 Letter Regarding Change in Accounting Principle
31.1 Certification of David Lilley, Chief Executive Officer, Pursuant to Rule 13a-14(a) of the Securities
Exchange Act
31.2 Certification of James P. Cronin, Chief Financial Officer, Pursuant to Rule 13a-14(a) of the Securities
Exchange Act
32.1 Certification of David Lilley, Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted
Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002
32.2 Certification of James P. Cronin, Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As
Adopted Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002
-29-